Latest 10-Q quarterly reports

Strategic Storage Trust VI, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing financial performance, property operations, and ongoing strategic initiatives.
NASDAQ
Tavia Acquisition Corp. reports Q1 2026 net income of $821,709, driven by interest income, with ongoing efforts to identify a business combination target.
NYSE
Andersen Group Inc. reported a 15.7% year-over-year revenue increase to $240.7 million for Q1 2026, but net income saw a significant decline due to increased operating expenses, particularly equity-based compensation.
NYSE
GCT Semiconductor Holding, Inc. reported a significant increase in net revenues for the first quarter of 2026, driven by strong performance in both product and service segments, while operating expenses decreased.
NYSE
AECOM's Q2 2026 filing shows a modest revenue increase driven by infrastructure spending, with improved gross profit margins despite a dip in net income.
NASDAQ
Mobile Infrastructure Corporation reports a net loss of $7.06 million for Q1 2026, with total revenues decreasing 3.7% year-over-year.
NASDAQ
CID Holdco, Inc. reported a significant revenue decline in Q1 2026, with substantial increases in operating expenses, while securing new financing arrangements.
NASDAQ
Rezolute, Inc. filed its Q3 2026 Form 10-Q, detailing financial performance and operational updates, including the disappointing outcome of its Phase 3 sunRIZE trial for congenital hyperinsulinism.
NASDAQ
AnaptysBio reports first-quarter 2026 financial results, detailing a net loss of $52.9 million and the successful separation of its First Tracks Biotherapeutics business.
Solsence, Inc. reported a decrease in total revenue for the first quarter of 2026 compared to the prior year, driven by lower sales in consumer products and advanced materials.
NASDAQ
iBio, Inc. reports significant R&D investment and progress in its preclinical pipeline, particularly for obesity and cardiometabolic diseases, while managing cash reserves and exploring strategic partnerships.
NYSE
QXO, Inc. reported a net loss of $227.1 million for the first quarter of 2026, impacted by significant acquisition activity and associated costs, while also announcing the proposed acquisition of TopBuild Corp.
NASDAQ
National CineMedia reported a 2.6% decrease in Q1 2026 revenue to $34.0 million, alongside a 3.6% rise in operating expenses, leading to a wider Adjusted OIBDA loss.
NASDAQ
Newbury Street II Acquisition Corp reports net income of $1.39 million for Q1 2026, primarily from interest income on its trust account, while continuing its search for a business combination.
NYSE
System1, Inc. reported a 50% year-over-year revenue decline for the first quarter of 2026, alongside a substantial impairment charge, raising concerns about its ability to continue as a going concern.
NYSE
Waters Corporation reported a net loss for the first quarter of 2026, significantly impacted by the recent acquisition of Becton, Dickinson and Company's Biosciences & Diagnostic Solutions business.
Intelligent Protection Management Corp. reported a 15.2% increase in revenue for Q1 2026, driven by managed IT services and procurement, while net loss narrowed due to reduced expenses and a prior year tax benefit.
AMEX
Hyliion Holdings Corp. reports increased R&D revenue and reduced operating expenses in Q1 2026, while continuing development of its KARNO Power Module.
NASDAQ
Space Asset Acquisition Corp. reports net income of $1,004,284 for the first quarter of 2026, driven by investment earnings, as it continues to seek a business combination.
NASDAQ
TherapeuticsMD, Inc. transitioned to a pharmaceutical royalty company, reporting increased license revenue and net income for the first quarter of 2026, while navigating ongoing legal disputes.
NASDAQ
Kura Oncology announces first quarter 2026 results, with $5.8 million in KOMZIFTI net product revenue and continued investment in pipeline development.
NASDAQ
Cyclerion Therapeutics reports Q1 2026 results, highlighting a significant net loss and ongoing preparations for a merger with Korsana Biosciences, while facing substantial going concern doubts.
NYSE
Alussa Energy Acquisition Corp. II reports net income of $2.2 million for Q1 2026, primarily driven by interest income from its trust account, while continuing its search for a business combination.
NASDAQ
Apex Treasury Corporation reported a net income of $2.67 million for the first quarter of 2026, primarily driven by interest income from its trust account.
NYSE
Brookfield Oaktree Holdings, LLC reported a net income of $32.4 million for Class A unitholders in Q1 2026, a significant improvement from a loss of $11.8 million in Q1 2025, driven by unrealized investment gains.
NASDAQ
Stratus Properties Inc. announced its Q1 2026 results, highlighting the Board's approval of a plan for complete liquidation and dissolution, subject to stockholder approval.
NYSE
D-Wave Quantum Inc. filed its Q1 2026 Form 10-Q, detailing a significant revenue decrease driven by system sales timing, substantial increases in operating expenses, and the completion of its acquisition of Quantum Circuits.
NASDAQ
Zentalis Pharmaceuticals reports Q1 2026 results, with a focus on advancing azenosertib clinical trials and managing cash runway.
NASDAQ
Maze Therapeutics, Inc. announced its first quarter 2026 financial results, highlighting progress in its clinical-stage drug development programs and a strong cash position.
NASDAQ
Hour Loop, Inc. reported a 15.8% increase in net revenues for Q1 2026, reaching $29.9 million, driven by higher order volumes, despite facing new trade tariffs and Amazon policy changes.